期刊文献+

血管紧张素II体外诱导神经干细胞分化为多巴胺能神经元的机制研究 被引量:2

The mechanism study of angiotensin II induces Neural stem cells differentiated into dopaminergic neurons
下载PDF
导出
摘要 目的探讨血管紧张素II(AngiotensinII,AII)诱导神经干细胞(Neural stem cells,NSCs)定向分化为多巴胺(Dopamine,DA)能神经元的过程中血管紧张素1型(AT1)受体和血管紧张素2型(AT2)受体所起的作用。方法在无血清培养基中分离培养NSCs,通过巢蛋白(nestin)免疫细胞化学对神经前体细胞进行鉴定;在此基础上,将第二代的NSCs在含10%胎牛血清的培养基中按照实验设计分为6组,分别是,A:对照组,B:AII组,C:AT1受体拮抗剂ZD7155组,D:AT1受体拮抗剂ZD7155+AII组,E:AT2受体拮抗剂PD123319组,F:AT2受体拮抗剂PD123319+AII组,观察NSCs向DA能神经元定向诱导分化情况。通过酪氨酸羟化酶(TH)免疫细胞化学进行DA能神经元鉴定,并观察各组DA能神经元突触的长度变化,通过实时荧光定量RT-PCR检测各实验组中TH基因表达水平。结果细胞团中可以看到nestin免疫阳性着色,实时荧光定量RT-PCR法检测B组、D组的TH基因表达水平高于对照组,差异有统计学意义(P<0.05),C、E、F组的TH基因表达水平与对照组比较无差异(P>0.05),各组DA能神经元的突触长度没有明显差别(P>0.05)。结论AII诱导产生DA能神经元的作用是由AT2受体介导,激活AT1、AT2受体均不能诱导DA能神经元突触延长或抑制突触延长。 Objective To explore the function of angiotensin type 1 and type 2(AT1 and AT2)recepters in the possible effects of angiotensin II induced the differentiation of dopaminegic phenotype neurons from neural stem cells(NSCs). Methods NSCs were cultured in the serum-free medium. NSCs were determined by Nestin immunocytochemical staining. On this basis,we difined 6 groups,A,control;B,AII;C,AT1 antagonist ZD7155;D,ZD7155+AII;E,AT2 antagonist PD123319;F,PD123319+AII. Differentiated cells were detemined by TH immunocytochemical staining to investigate the process length and real-Time PCR to detect the expression of TH mRNA level. Results We could find Nestin-positive cells. Real-Time PCR revealed that the TH mRNA expression of group B and D were significantly higher than the control group(P0.05). There was no significant difference in groups of process length of TH+ positive cells. Conclusion AII induced the differentiation of NSCs into DA neurons via AT2 recepter. AT1/AT2 recepter did not involve in the increasing of the length process of TH+ positive cells.
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2010年第3期199-202,共4页 Journal of Apoplexy and Nervous Diseases
基金 广西自然科学基金(桂科自0832140)
关键词 神经干细胞 分化 多巴胺能神经元 血管紧张素II AT1和AT2受体 Neural stem cells Differentiation Dopaminergic neuron Angiotensin II AT1 and AT2 recepters
  • 相关文献

参考文献8

  • 1McKinley M J, Albiston AL, Allen AM, et al. The brain renin-angiotensin system:location and physiological roles[ J]. Int J Biochem Cell Biol,2003,35:901-918.
  • 2Ge J, Barnes NM. Alterations in angiotensin AT1 and AT2 receptor subtype levels in brain regions from patients with neurodegenerative disorders[J]. Eur J Pharmacol,1996,297:299-306.
  • 3Dinh DT, Frauman AG, Johnston CI, et al. Angiotensin receptors : distribution, signaling and function [ J]. Clin Sci ,2001,100:481-492.
  • 4Armando I, Jezova M, Bregonzio C. Angiotensin II AT1 and AT2 receptor types regulate basal and stress-induced adrenomedullary catecholamine production through transcriptional regulation of tyrosine hydroxylase[ J]. Ann N Y Acad Sci,2004,1018:302-309.
  • 5Rodriguez-Pallares J, Quiroz CR, Parga JA, et al. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors [ J ]. Europ J Neurosci, 2004,20 : 1489-1498.
  • 6Rey P, Lopez-Real A, Sanchez-Iglesias S. Angiotensin type-1-receptor antagonisits reduce 6-hydrexypamine toxicity for dopaminegic neurons [ J]. Neurobiol Aging,2007,28:555-567.
  • 7Reed G, Moeller I, Mendelsohn FA. A novel action of angiotensin peptides in inhibiting neurite outgrowth from isolated chick sympathetic neurons in culture [ J ]. Neurosci Lett, 1996,210 : 209 -212.
  • 8Yang H, Shaw G, Raizada MK. ANG II stimulation of neuritogenesis involves protein kinase B in brain neurons [ J ]. Am J Physiol Regul Integr Comp Physiol,2002,283 : 107-114.

同被引文献23

  • 1Harmon GJ. RNA interference [ J]. Nature,2002,418 (6894) : 244 - 251.
  • 2Dorsett Y, Tuschl T. siRNA:Applications in functional genomics and potential as therapeutics[J]. Nat Rev Drug Discov,2004,3(4) :318 - 329.
  • 3Thomas B, Beal MF. Parkinson's disease[ J]. Hum Mol Genet,2007, 16(2) :183 - 194.
  • 4Wagner J, Akerug P, Castro DS, et al. Induction of a midbraid dopam- inergic phenotype in nurrl-overexpressing neural stem cells by type 1 astrosytes [ J ]. Nat Biotechnol, 1999,17 (7) :653 - 654.
  • 5Li JM, Mogi M, Tsukuda K, et al. Angiotensin H-Induced Neural Dif- ferentiation via Angiotensin II Type 2 (AT2) Receptor-MMS2 Cascade Involving Interaction between AT2 Receptor-Interacting Protein and Src Homology 2 Domain-Containing Protein-Tyrosine Phosphatase 1 [ J ]. Mol Endocfinol,2007,21 ( 2 ) :499 - 511.
  • 6Mogi M, Li JM, Iwanami J, et al. AngiotensinⅡ Type-2 ReceptorStimulation Prevents Neural Damage by Transcriptional Activation of Methyl Methanesulfonate Sensitive 2 [ J ]. Hypertension, 2006,48 (1):141-148.
  • 7Min LJ, Mogi M, Iwanami J, et al. Angiotensin Ⅱ Type 2 Receptor Deletion Enhances Vascular Senescence by Methyl Methanesulfonate Sensitive 2 Inhibition [ J ]. Hypertension, 2008,51 ( 5 ) : 1339 - 1344.
  • 8Wu P, Ye Y, Svendsen CN. Transduction of human neural progenitorcells using recombinant adeno-associated viral vectors [ J ]. Gene Ther,2002,9 (4) :245 - 255.
  • 9Hughes SM, Moussavi-Harami F, Sauter SL, et al. Viral-mediated gene transfer to mouse primary neural progenitor cells [ J ]. Mol Ther,2002,5 ( 1 ) : 16 - 24.
  • 10Thomas B, Beal MF. Parkinson's disease[J]. Hum Mol Genet, 2007, 16 (R2): R183-194.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部